[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-TKnt1sUTbJ89DAfZviiEeKgvxhrfjMPlRBGvfe0jjs":8,"$fAwafvEHNc0uyxI8EO3ScUrZiK9NgUvPRgryfevBxOGg":55,"$fE2bIl4x53hEWv7ywl55VAszS6hviNdEWsud1IRJZXXk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},47036,868612,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//aEjvqWJyaGzRDDYxpbM3JGk58uOu7fQX.png","李俊杰","桓台县人民医院","血管外科","主治医师",16,0,"R-CHOP及关键药物的安全用药全攻略","","https://ystcdn.venuertc.com/venue/AI/713f5545-261c-469c-b8b6-f33f5dca3cd9.jpg","\u003Cdiv class=\"med-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"med-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">R-CHOP及关键药物的安全用药全攻略\u003C/h2>\n  \u003Cdiv class=\"med-guide-intro med-guide-bg1\">\n    \u003Cp>\n      在治疗胃弥漫大B细胞淋巴瘤等血液系统疾病时，R-CHOP方案是非常常见且重要的药物组合。它包括利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松。每种药物有自己的特点和注意事项。这次我们就针对R-CHOP方案中的五种药物，详细说说六大用药要点，帮你避开常见的用药误区。🌿\n    \u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 01 剂型和服用方法要分清 -->\n  \u003Csection class=\"med-guide-section med-guide-bg2\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型和服用方法要分清 🩺\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗（Rituximab）：\u003C/strong>属于静脉注射用生物制剂，通常需要在医院输注。注射前药瓶用专用溶剂稀释，严禁口服、肌肉注射或自行操作。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺（Cyclophosphamide）：\u003C/strong>有注射剂和片剂两种。片剂口服要整片吞服，不能嚼碎；注射剂需要在医院，由专业人员静脉滴注或肌肉注射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星（Doxorubicin）：\u003C/strong>必须静脉给药，严禁皮下或肌肉注射。注射过程需严格避光操作，不可自行在家服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱（Vincristine）：\u003C/strong>只可静脉注射，严禁椎管内、肌肉或皮下注射。具体剂量由医护人员操作，切记不可自行用药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>泼尼松（Prednisone）：\u003C/strong>为片剂，口服使用。建议早上一次性服用，用温水整片吞服，配合餐后效果更佳，避免刺激胃黏膜。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">正确做法：按医生指示使用对应剂型和给药途径，严禁自行调整。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 02 组合用药顺序和间隔时间 -->\n  \u003Csection class=\"med-guide-section med-guide-bg3\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 组合用药顺序和间隔时间 ⏳\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        R-CHOP方案内各药物通常分在不同天给药，泼尼松每日口服5天，其余四种药物多为第1天集中静脉注射。\n      \u003C/li>\n      \u003Cli>\n        利妥昔单抗通常最先给药，因为可能引发过敏反应，需要严密观察。多柔比星、长春新碱、环磷酰胺随后给予。\n      \u003C/li>\n      \u003Cli>\n        不同药物间需遵医嘱严格间隔，避免药物因相互影响而降低疗效或增加副作用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">如需居家口服泼尼松，务必保持每天用药时间一致。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 03 作用机制简析 -->\n  \u003Csection class=\"med-guide-section med-guide-bg4\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药理作用一览表 🔬\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗：\u003C/strong>属抗CD20单克隆抗体，通过结合B淋巴细胞表面的CD20抗原，激活免疫系统杀伤异常细胞（Maloney et al., 1997）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong>为烷化剂类细胞毒药，破坏DNA结构阻止细胞分裂（Colvin, 1980）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星：\u003C/strong>插入DNA链和形成自由基，干扰DNA复制和修复，从而抑制异常细胞生长（Gewirtz, 1999）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱：\u003C/strong>阻止微管蛋白聚合，阻断细胞有丝分裂（Jordan & Wilson, 2004）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>泼尼松：\u003C/strong>为糖皮质激素，能够调节不同的免疫及炎症反应通路，辅助提高治疗效果（Hapgood & Avenant, 2015）。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">每种药物有其独特的机制，联合使用达到协同作用。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 04 药物相互作用须知 -->\n  \u003Csection class=\"med-guide-section med-guide-bg5\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用须知 ⚠️\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>多柔比星+环磷酰胺：\u003C/strong>可加重骨髓抑制，需频繁监测血象，避免同时服用其他抑制骨髓的药物如甲氨蝶呤。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗：\u003C/strong>联合免疫抑制剂（如他克莫司）时，免疫抑制作用增强，易感感染。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱：\u003C/strong>和抗真菌药物伊曲康唑等共用时，增加神经毒性风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>泼尼松：\u003C/strong>和NSAIDs如阿司匹林、布洛芬同用，容易刺激胃肠道，增加出血风险。\n      \u003C/li>\n      \u003Cli>\n        食物影响：泼尼松最好餐后服用，减少胃部不适；环磷酰胺片剂宜早晨服，保证日间多饮水促进代谢。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">如已有服用其他药物的情况，务必主动告知医生。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 05 用药监测和特殊人群调整 -->\n  \u003Csection class=\"med-guide-section med-guide-bg6\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药监测和特殊人群调整 🧑‍⚕️\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>老年患者：\u003C/strong>多柔比星、长春新碱等药物使用时，需考虑器官功能下降，剂量按体重和肾肝功能调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肾、肝功能不全：\u003C/strong>环磷酰胺、长春新碱和多柔比星需慎用，部分需降低剂量或延长给药间隔。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇和哺乳期：\u003C/strong>这几类药物对胎儿和哺乳婴儿潜在危害极高，绝大多数禁用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>儿童：\u003C/strong>剂量严格按体重、体表面积计算，全程专业医师监护。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药监测：\u003C/strong>R-CHOP期间需密切监测血常规、肝肾功能、心功能等。多柔比星有心脏毒性风险（Swain et al., 2003），使用前后需做心电图、超声心动图等检查。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">有基础疾病、用药史时，请主动和医师沟通，必要时调整剂量和用药方案。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 06 常见不良反应与应对措施 -->\n  \u003Csection class=\"med-guide-section med-guide-bg7\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与应对措施 🚨\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗：\u003C/strong>主要是输注相关反应，如发热、寒战等，有时会有短暂血压波动。正确做法：首次注射时现场密切观察，如果身体不适需立即通知医护人员。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong>可能引起恶心、脱发、骨髓抑制。多饮水有助于减少尿路副作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星：\u003C/strong>可致心脏毒性，表现在心悸、心力衰竭等；注射期有时会造成静脉刺激和局部疼痛。用药期间需进行心脏功能监测。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱：\u003C/strong>常见神经系统副作用，如麻木、乏力。出现明显神经反应务必第一时间告知医生。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>泼尼松：\u003C/strong>容易引起消化道不适、血糖升高、睡眠障碍等。餐后服用，规律饮食能降低胃肠道反应。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">遇到严重恶心、心动过缓、明显出血等表现时应立即就医。\u003C/span>\n    \u003Cdiv class=\"med-guide-case\">\n      \u003C!-- 用药案例 -->\n      \u003Cstrong>案例：\u003C/strong>有位女性患者在使用R-CHOP中的多柔比星期间，出现轻度心悸反应，经及时减量并加强监测后，顺利完成疗程，未发生不可逆损害。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 药物储存与有效期 -->\n  \u003Csection class=\"med-guide-section med-guide-bg8\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药物储存与有效期 📦\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗、长春新碱、多柔比星注射液：\u003C/strong>未开封需2-8°C冷藏，开封后按说明书要求使用，剩余部分通常应弃去。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺片剂、泼尼松：\u003C/strong>常温避光保存，放于干燥处，避免儿童接触。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>注意：\u003C/strong>药物切勿自行拆分包装、随意混用或更换存放容器。过期药品需交由药店或专业医废回收点处理，切勿自行丢弃。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">保存好药物说明书，随时查阅储存和有效期信息，避免因变质影响药效或安全性。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 08 漏服、过量及紧急处理 -->\n  \u003Csection class=\"med-guide-section med-guide-bg9\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服及过量应急措施 ⚕️\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>泼尼松片剂：\u003C/strong>若漏服一次，可当日尽早补服；若接近下次服药时间，则略过漏服，不建议加倍剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>其他注射药物：\u003C/strong>务必由医护人员统一管理，切勿自行补打、重复用药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量风险：\u003C/strong>如不慎用药过量，可能加重毒副作用。需及时前往医院求助。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">口服药物尽量每天同一时间服用，按疗程完成，不随意中断。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 09 关键用药细节和友情提示 -->\n  \u003Csection class=\"med-guide-section med-guide-bg10\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 关键细节总结 💡\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        R-CHOP中的每种药物用法各异，绝对不可混淆剂型和用路，尤其是长春新碱、利妥昔单抗等生物制剂。\n      \u003C/li>\n      \u003Cli>\n        不论自觉身体状况如何，用药期间都需密切监测血常规、肝肾心功能等，及时与医护团队交流。\n      \u003C/li>\n      \u003Cli>\n        组合化疗药物相互作用多，其他用药、保健品及补充剂使用要提前报备。\n      \u003C/li>\n      \u003Cli>\n        输液药品保存条件普遍苛刻，居家管理时要特别留意；口服药则重在防潮、避光。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"med-guide-tips\">安全用药，需严守医嘱、规范操作，有疑问及时咨询专业人员。\u003C/span>\n  \u003C/section>\n  \n  \u003C!-- 引用文献 -->\n  \u003Csection class=\"med-guide-section med-guide-refbg\">\n    \u003Ch2 class=\"med-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"med-guide-ref-list\">\n      \u003Cli>Maloney, D. G., Liles, T. M., Czerwinski, D. K., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A., ... & Levy, R. (1997). Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. \u003Ci>Blood, 90\u003C/i>(6), 2188-2195.\u003C/li>\n      \u003Cli>Colvin, M. (1980). Alkylating agents and platinum antitumor compounds. \u003Ci>Cancer Chemotherapy and Pharmacology, 5\u003C/i>(S1), S1–S7.\u003C/li>\n      \u003Cli>Gewirtz, D. A. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. \u003Ci>Biochemical Pharmacology, 57\u003C/i>(7), 727–741.\u003C/li>\n      \u003Cli>Jordan, M. A., & Wilson, L. (2004). Microtubules as a target for anticancer drugs. \u003Ci>Nature Reviews Cancer, 4\u003C/i>(4), 253–265.\u003C/li>\n      \u003Cli>Hapgood, J. P., & Avenant, C. (2015). Glucocorticoid receptors: Effects on cell proliferation, apoptosis, and tumorigenesis. \u003Ci>Journal of Steroid Biochemistry and Molecular Biology, 145\u003C/i>, 16-23.\u003C/li>\n      \u003Cli>Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003). Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. \u003Ci>Cancer, 97\u003C/i>(11), 2869–2879.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.med-guide-container {\n  max-width: 810px;\n  margin: 38px auto;\n  padding: 20px 28px 38px 28px;\n  background: #fdfcf9;\n  border-radius: 14px;\n  box-shadow: 0 4px 22px 0 rgba(113,113,120,0.1);\n  font-family: \"Helvetica Neue\", Arial, sans-serif;\n  color: #222;\n  font-size: 18px;\n  line-height: 1.88;\n}\n.med-guide-title {\n  text-align: center;\n  font-size: 30px;\n  color: #20719a;\n  letter-spacing: 2px;\n  font-weight: 700;\n  margin-bottom: 34px;\n  padding-top: 24px;\n}\n.med-guide-subtitle {\n  font-size: 22px;\n  color: #185553;\n  font-weight: 600;\n  letter-spacing: 1px;\n  padding: 10px 18px 10px 0;\n  margin: 0;\n  background: linear-gradient(90deg,#e3f4fd 0,#e9f6f0 100%);\n  border-radius: 7px 18px 18px 7px;\n  margin-bottom: 15px;\n}\n.med-guide-bg1 {\n  background: linear-gradient(90deg,#f8fbfd 0,#eaf4fc 100%);\n  border-radius: 12px;\n  margin-bottom: 28px;\n  padding: 16px 28px 12px 22px;\n}\n.med-guide-bg2 {\n  background: linear-gradient(90deg,#ecf7ec 0,#f6fdfa 100%);\n}\n.med-guide-bg3 {\n  background: linear-gradient(90deg,#fdf7ef 0,#fafcf6 100%);\n}\n.med-guide-bg4 {\n  background: linear-gradient(90deg,#eaf2fc 0,#f9fafd 100%);\n}\n.med-guide-bg5 {\n  background: linear-gradient(90deg,#fdfcf7 0,#f4f8eb 100%);\n}\n.med-guide-bg6 {\n  background: linear-gradient(90deg,#e9f8f9 0,#f8fbfc 100%);\n}\n.med-guide-bg7 {\n  background: linear-gradient(90deg,#faf7fd 0,#f9fbf5 100%);\n}\n.med-guide-bg8 {\n  background: linear-gradient(90deg,#f9f6fd 0,#f7fcf5 100%);\n}\n.med-guide-bg9 {\n  background: linear-gradient(90deg,#f7fafd 0,#f7f6fa 100%);\n}\n.med-guide-bg10 {\n  background: linear-gradient(90deg,#f6fcfb 0,#fdf7fa 100%);\n}\n.med-guide-section {\n  border-radius: 11px;\n  margin-bottom: 29px;\n  padding: 18px 30px 16px 22px;\n  box-sizing: border-box;\n}\nul {\n  margin: 10px 0 10px 30px;\n  padding: 0;\n}\nul li {\n  margin-bottom: 7px;\n  list-style: disc;\n}\n.med-guide-tips {\n  display: block;\n  background: #e7f5fa;\n  border-left: 3px solid #53b7de;\n  font-size: 16px;\n  color: #23577b;\n  margin: 18px 0 0 0;\n  padding: 10px 14px 8px 12px;\n  border-radius: 5px 15px 15px 5px;\n}\n.med-guide-case {\n  background: #fceee7;\n  margin-top: 16px;\n  padding: 10px 15px 10px 15px;\n  border-left: 3px solid #f48c5a;\n  font-size: 16px;\n  border-radius: 5px 11px 11px 5px;\n}\n.med-guide-refbg {\n  background: linear-gradient(90deg,#f1f7fa 0,#fbfdfd 100%);\n  border-radius: 11px;\n  padding: 20px 20px 18px 25px;\n  margin-bottom: 0;\n}\n.med-guide-ref-list {\n  font-size: 15px;\n  color: #17233d;\n  margin: 8px 0 0 22px;\n}\n@media (max-width: 1150px) {\n  .med-guide-container {\n    max-width: 98%;\n    padding: 8px;\n  }\n}\n@media (max-width: 700px) {\n  .med-guide-title {\n    font-size: 22px;\n    padding-top: 13px;\n    margin-bottom: 19px;\n  }\n  .med-guide-section, .med-guide-bg1, .med-guide-refbg {\n    padding: 11px 8px 11px 7px;\n  }\n  .med-guide-subtitle {\n    font-size: 18px;\n    padding: 7px 7px 7px 0;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"med-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"med-guide-title\" style=\"color: rg",535,"2025-07-08 10:02:18","R-CHOP, 利妥昔单抗, 环磷酰胺, 多柔比星, 长春新碱, 血液系统疾病, 用药监测, 不良反应","本文详解R-CHOP方案五种药物的安全用药要点，帮助患者有效避免常见用药误区。适合血液系统疾病患者和家属关注！","2025-07-08 18:52:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]